Toxin-Related Benzodiazepine-Refractory Status Epilepticus Causes, Management
In a post hoc analysis, researchers investigated the safety and efficacy of second-line medications in patients with toxin-related seizures.
In a post hoc analysis, researchers investigated the safety and efficacy of second-line medications in patients with toxin-related seizures.
Researchers sought to improve the prognostication of long-term mortality following a status epilepticus diagnosis.
Researchers sought to identify early posttraumatic seizure (EPS) risk factors, evaluate the morbidity and mortality involved with EPS, and develop a risk assessment prediction model for EPS.
Hospitalization for status epilepticus is associated with elevated mortality and costs that increase with disease refractoriness.
Ketamine infusion significantly decreased seizure burden within 24 hours in patients with super-refractory status epilepticus.
During COVID-19, clinicians will be challenged by a lack of ICU resources and ventilators to manage patients with status epilepticus.
Individuals with vs without status epilepticus were found to have a greater prevalence of cardiovascular risk factors and a higher risk of developing cardiovascular diseases.
Results suggest that levetiracetam could be considered as an alternative treatment to phenytoin for second-line management of pediatric convulsive status epilepticus.
Investigators examined various scoring systems to predict recovery to premorbid neurological and functional status in critically ill patients with status epilepticus.
Researchers sought to determine whether the Salzburg Consensus Criteria yielded similar diagnostic results by an inexperienced EEG reader compared with an experienced EEG reader not using the SCC.